News

May 19 2016
A new online tool that helps Canadian patients and caregivers get the information they need and help alleviate anxiety or confusion they may be feeling after a chronic lymphocytic leukemia (CLL) diagnosis.
Apr 06 2016
Lymphoma Canada is preparing submissions to the pan­Canadian Oncology Drug Review (pCODR) for: Ibrutinib (Imbruvica) for patients with previously untreated CLL for whom fludarabine-based treatment is considered inappropriate and Venetoclax (ABT-199) for patients with relapsed/refractory CLL

Pages